Gardasil Welcome to the GARDASIL Access Program The GARDASIL® Access Program plans to make available at least three million doses of GARDASIL® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] a vaccine designed to prevent cervical cancer caused by HPV types 16 and 18, for use in projects in eligible low income countries throughout the world. Gardasilaccessprogram.net~Site InfoWhoisTrace RouteRBL Check
